EMD-21231
De novo designed tetrahedral nanoparticle T33_dn2 presenting BG505 SOSIP trimers
EMD-21231
Single-particle4.6 Å
Deposition: 22/01/2020Map released: 12/08/2020
Last modified: 06/03/2024
Sample Organism:
synthetic construct
Sample: De novo designed tetrahedral nanoparticle BG505 SOSIP-T33_dn2
Fitted models: 6vl6
Deposition Authors: Ward AB, Antanasijevic A
Sample: De novo designed tetrahedral nanoparticle BG505 SOSIP-T33_dn2
Fitted models: 6vl6
Deposition Authors: Ward AB, Antanasijevic A
Targeting HIV Env immunogens to B cell follicles in nonhuman primates through immune complex or protein nanoparticle formulations.
Martin JT,
Cottrell CA 
,
Antanasijevic A,
Carnathan DG,
Cossette BJ,
Enemuo CA,
Gebru EH,
Choe Y,
Viviano F,
Fischinger S ,
Tokatlian T ,
Cirelli KM,
Ueda G ,
Copps J ,
Schiffner T ,
Menis S,
Alter G ,
Schief WR ,
Crotty S,
King NP ,
Baker D,
Silvestri G,
Ward AB,
Irvine DJ
(2020) NPJ Vaccines , 5 , 72 - 72
,
Antanasijevic A,
Carnathan DG,
Cossette BJ,
Enemuo CA,
Gebru EH,
Choe Y,
Viviano F,
Fischinger S ,
Tokatlian T ,
Cirelli KM,
Ueda G ,
Copps J ,
Schiffner T ,
Menis S,
Alter G ,
Schief WR ,
Crotty S,
King NP ,
Baker D,
Silvestri G,
Ward AB,
Irvine DJ
(2020) NPJ Vaccines , 5 , 72 - 72
Grant Support:
- Bill & Melinda Gates Foundation: OPP1115782 (United States)